Partner Richard Manning will moderate a panel at the 8th Annual American Society of Health Economists meeting in Washington, DC. The panel is titled “Setting Drug Prices in Medicare: Toward a Competitive Market?” In an effort to reduce prescription drug spending, Congress and the administration are examining a variety of legislative and regulatory actions—for example, setting prices for drugs in Part B by referencing the prices of a basket of drugs from foreign markets. Dr. Manning will lead the panel in its review of recent proposals for controlling prices in Medicare, the degree to which they strengthen market competition, and implications for static and dynamic efficiency.
June 24, 2019
Event Sponsor: American Society of Health Economists